KELLY MANGANELLO: Open Payments
NPI 1669638953 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,009 in 80 payments from 16 companies in 2025. Trend: 2023 $1,483 · 2024 $1,463 · 2025 $1,009
Food & beverage: $1,009
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $288 |
| Novartis Pharmaceuticals Corporation | 32 | $170 |
| GENZYME CORPORATION | 5 | $135 |
| UCB, Inc. | 4 | $77 |
| Amgen Inc. | 2 | $50 |
| E.R. Squibb & Sons, L.L.C. | 3 | $49 |
| Botanix SB Inc | 2 | $43 |
| Janssen Biotech, Inc. | 1 | $34 |
| Chiesi USA, Inc. | 1 | $30 |
| LEO Pharma Inc. | 1 | $29 |
Products named: SKYRIZI, RINVOQ, COSENTYX, DUPIXENT, Bimzelx, OTEZLA, Sotyktu, SOFDRA.
Industry payments across NY — which companies pay providers there.
